北京大学学报(医学版) ›› 2018, Vol. 50 ›› Issue (5): 767-773. doi: 10.19723/j.issn.1671-167X.2018.05.001

• 论著 •    下一篇

二甲双胍与脂联素对子宫内膜癌细胞增殖的作用

王小慧*,张岩*△,刘林枝,尚晨光   

  1. (北京大学第一医院妇产科, 北京100034)
  • 出版日期:2018-10-18 发布日期:2018-10-18
  • 通讯作者: 张岩 E-mail: shamruck@126.com
  • 基金资助:
     国家自然科学基金(81272870)

Effects of metformin and adiponectin on endometrial cancer cells growth

WANG Xiao-hui*, ZHANG Yan*△, LIU Lin-zhi, SHANG Chen-guang   

  1. (Department of Obstetrics and Gynecology,Peking University First Hospital, Beijing 100034, China)
  • Online:2018-10-18 Published:2018-10-18
  • Contact: ZHANG Yan E-mail: shamruck@126.com
  • Supported by:
    Supported by the National Natural Science Foundation of China (81272870)

摘要: 目的:探讨二甲双胍对子宫内膜癌细胞脂联素受体的作用及联合使用二甲双胍和脂联素对子宫内膜癌细胞增殖的影响。方法:用CCK8法检测不同浓度二甲双胍和脂联素对IK(ishikawa)和HEC--1B两种子宫内膜癌细胞系增殖的影响。用实时荧光定量RT-PCR(quantitative real time RT-PCR, qRT-PCR)法和Western blot法检测不同浓度二甲双胍作用下IK和HEC-1B细胞脂联素受体[包括脂联素受体1(adiponectin receptor 1,AdipoR1)和脂联素受体2(adiponectin receptor 2,AdipoR2)]的变化及磷酸腺苷活化的蛋白激酶(adenosine monophosphate-activated protein kinase,AMPK)通路抑制剂compound C对以上作用的影响。结果:(1)二甲双胍和脂联素均可抑制IK和HEC-1B细胞的生长增殖,并且都呈时间和浓度依赖性(P<0.05);(2)二甲双胍和脂联素对IK和HEC-1B细胞有协同抑制增殖作用,IK细胞药物联合指数(combination index,CI)为0.906 34,HEC-1B细胞CI为0.827 65;(3)用5 mmol/L和10 mmol/L的二甲双胍分别刺激IK和HEC-1B细胞48 h,细胞AdipoR1和AdipoR2 mRNA的水平较对照组(0 mmol/L)显著增高(IK:AdipoR1:5 mmol/L和10 mmol/L组P均<0.001,AdipoR2:5 mmol/L组P<0.001;HEC-1B:AdipoR1:5 mmol/L组P<0.001,10 mmol/L组P=0.023,AdipoR2:5 mmol/L组P<0.001,10 mmol/L组P=0.024), 联合compound C时,该作用被抑制,与对照组(0 mmol/L)相比AdipoR1和AdipoR2 mRNA水平差异无统计学意义(P>0.05);(4)用5 mmol/L和10 mmol/L的二甲双胍分别刺激IK和HEC-1B细胞48 h,细胞AdipoR1和AdipoR2的蛋白水平较对照组(0 mmol/L)显著增高(IK:AdipoR1:5 mmol/L组P=0.04,10 mmol/L组P=0.033;AdipoR2:5 mmol/L组P=0.044,10 mmol/L组P=0.046。HEC-1B:AdipoR1:5 mmol/L组P=0.04,10 mmol/L组P=0.049;AdipoR2:5 mmol/L组P=0.043,10 mmol/L 组P=0.035), 联合compound C时,该作用被抑制,与对照组(0 mmol/L)相比,AdipoR1和AdipoR2蛋白表达差异无统计学意义(P>0.05)。结论:二甲双胍和脂联素具有协同抑制子宫内膜癌细胞IK和HEC-1B增殖的作用,二甲双胍可上调子宫内膜癌细胞脂联素受体的表达,AMPK通路参与这一过程。

关键词: 二甲双胍, 脂联素, 子宫内膜癌, 脂联素受体

Abstract: Objective:To determine the effect of metformin and adiponectin on the proliferation of EC cells and the relationship between metformin and adiponectin. Methods: The proliferation impact of different concentrations of metformin and adiponectin on two types of EC cells ishikawa (IK) and HEC-1B was confirmed by CCK-8 method. qRT-PCR and Western blot were used to detect the effect of different concentrations of metformin on the changes of adiponectin receptors (AdipoR1 and AdipoR2) of the EC cells both in mRNA and protein level and the role of compound C, an adenosine monophosphate-activated protein kinase (AMPK) inhibitor, on the above effects. Results: (1) Both metformin and adiponectin could significantly promote the proliferation of endometrial cancer (EC) cells in a time and concentration dependent manner (P<0.05).(2)Metformin and adiponectin had synergy anti-proliferative effect on EC cells and the combination index (CI) value of IK cells was 0.906 34 and of HEC-1B cells was 0.827 65.(3)qRT-PCR was used to detect the mRNA levels of AdipoR1 and AdipoR2 after 5 mmol/L and 10 mmol/L metformin, respectively, stimulating IK and HEC-1B cells for 48 hours and the mRNA expressions of AdipoR1 and AdipoR2 were significantly increased when compared with the control group (0 mmol/L)(IK: AdipoR1 of 5 mmol/L and 10 mmol/L group: P<0.001,AdipoR2 of 5 mmol/L group: P<0.001; HEC-1B: AdipoR1 of 5 mmol/L group: P<0.001, 10 mmol/L group: P=0.023, AdipoR2 of 5 mmol/L group: P<0.001, 10 mmol/L group: P=0.024). When combined with compound C, the RNA levels of AdipoR1 and AdipoR2 were not different compared with the control group (0 mmol/L, P>0.05). (4) Western blot was used to detect the protein levels of AdipoR1 and AdipoR2 after 5 mmol/L and 10 mmol/L metformin, stimulating IK and HEC-1B cells for 48 hours and the protein level was significantly increased when compared with the control group (0 mmol/L)(IK: AdipoR1 of 5 mmol/L group: P=0.04, 10 mmol/L group: P=0.033, AdipoR2 of 5 mmol/L group: P=0.044, 10 mmol/L group: P=0.046; HEC-1B: AdipoR1 of 5 mmol/L group: P=0.04, 10 mmol/L group: P=0.049, AdipoR2 of 5 mmol/L group: P=0.043, 10 mmol/L group: P=0.035). When combined with compound C,the protein levels of AdipoR1 and AdipoR2 were not different compared with the control group (0 mmol/L, P>0.05). Conclusion: We find that metformin and adiponectin have synergy anti-proliferative effect on EC cells. Besides, metformin can increase adiponectin receptors expressions of EC cells both in mRNA and protein levels and this effect is accomplished by the activation of AMPK signaling pathway.

Key words: Metformin, Adiponectin, Endometrial cancer, Adiponectin receptor

中图分类号: 

  •  
[1] 于欢,杨若彤,王斯悦,吴俊慧,王梦莹,秦雪英,吴涛,陈大方,武轶群,胡永华. 2型糖尿病患者使用二甲双胍与缺血性脑卒中发病风险的队列研究[J]. 北京大学学报(医学版), 2023, 55(3): 456-464.
[2] 梁丽,李鑫,农琳,董颖,张继新,李东,李挺. 子宫内膜癌微卫星不稳定性分析: 微小微卫星变换的意义[J]. 北京大学学报(医学版), 2023, 55(2): 254-261.
[3] 森本智惠子,王益勤,周蓉,王建六. 子宫内膜非典型增生及子宫内膜癌患者保留生育功能治疗的临床研究[J]. 北京大学学报(医学版), 2022, 54(5): 936-942.
[4] 王晓,贺丹,李文婷,阿迪拉·斯依提,韩蕊,董颖. 144例维吾尔族与汉族女性子宫内膜癌微小RNA表达特点及临床意义[J]. 北京大学学报(医学版), 2020, 52(3): 570-577.
[5] 达娃次仁, 赵锋, 齐永芬, 陈路增, 霍勇. 脂联素及其受体在吡格列酮抑制ApoE基因敲除小鼠主动脉粥样硬化中的作用[J]. 北京大学学报(医学版), 2009, 41(2): 174-178.
[6] 王学英, 郭艳红, 郭丽君, 高炜. 血浆脂联素与冠状动脉病变程度的相关性分析[J]. 北京大学学报(医学版), 2007, 39(6): 599-602.
[7] 童玉, 黄丹珊, Michael BRYER-ASH. 球形脂联素、葡萄糖和游离脂肪酸对胰岛β细胞单磷酸腺苷激活的蛋白激酶和乙酰辅酶A羧化酶磷酸化的影响[J]. 北京大学学报(医学版), 2006, 38(6): 609-613.
[8] 王念鸿, 郭晓蕙, 王薇. 降糖及调脂治疗对OLETF大鼠血浆和胃组织中ghrelin水平的影响[J]. 北京大学学报(医学版), 2006, 38(6): 603-608.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!